These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19753849)

  • 1. [Re: the editorial in number 4, volume 28, 2008. "Cervical cancer control in Colombia: achievements and challenges of cytology based programs"].
    Calvache AE
    Biomedica; 2009 Mar; 29(1):161-2; author reply 162-3. PubMed ID: 19753849
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cervical cancer control in Colombia: achievements and challenges of cytology based programs].
    Murillo R
    Biomedica; 2008 Dec; 28(4):467-70. PubMed ID: 19462552
    [No Abstract]   [Full Text] [Related]  

  • 3. An effective and affordable cervical carcinoma screening programme for Sri Lanka.
    Kumarasinghe MP
    Ceylon Med J; 1999 Dec; 44(4):156-8. PubMed ID: 10895264
    [No Abstract]   [Full Text] [Related]  

  • 4. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
    Albuisson F; Anger E; Baron V; Cartier I; Dorne H; Dubois-Gordeff A; Hassoun J; Jouannelle A; Labbé S; Locquet D; Marsan C; Martin E; Michiels-Marzias D; Molinié V; Mottot C; Mueller B; Vacher-Lavenu MC; Vincent S; Vuong PN
    Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening from the public health perspective.
    Steiner C
    Acta Cytol; 1989; 33(4):471-4. PubMed ID: 2750437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendations from the experimental sites for implementing organized cervical cancer screening in France].
    Baudier F; Schapman S; Giordanella JP
    Sante Publique; 2000 May; 12 Spec No():71-88. PubMed ID: 10989630
    [No Abstract]   [Full Text] [Related]  

  • 7. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
    Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
    Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality assurance in cervical cytopathology.
    Light AM
    Cytopathology; 1997 Aug; 8(4):290-2. PubMed ID: 9252748
    [No Abstract]   [Full Text] [Related]  

  • 9. European guidelines on cervical screening.
    Smith JH; Desai MS
    Cytopathology; 2007 Aug; 18(4):211-2. PubMed ID: 17635160
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality control in cytopathology applied to screening for cervical carcinoma.
    Marsan C
    Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cervical cancer screening. False negative smears].
    Vassilakos P; De Marval F; Muñoz M
    Rev Med Suisse Romande; 1997 Aug; 117(8):597-601. PubMed ID: 9340714
    [No Abstract]   [Full Text] [Related]  

  • 12. Using urbanization profiles to assess screening performance.
    Boon ME; Kok LP
    Diagn Cytopathol; 2004 Apr; 30(4):243-6. PubMed ID: 15048958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality assessment in the age of machine-aided cervical cytology screening.
    Renshaw AA
    Cancer; 2004 Dec; 102(6):345-7. PubMed ID: 15540251
    [No Abstract]   [Full Text] [Related]  

  • 14. Comprehensive evaluation of cervical cancer screening programs: the case of Colombia.
    Murillo R; Wiesner C; Cendales R; Piñeros M; Tovar S
    Salud Publica Mex; 2011; 53(6):469-77. PubMed ID: 22282139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An operative model: verification of the quality of the screening Pap test ].
    Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
    Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
    [No Abstract]   [Full Text] [Related]  

  • 16. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.
    Wiener HG; Klinkhamer P; Schenck U; Arbyn M; Bulten J; Bergeron C; Herbert A
    Cytopathology; 2007 Apr; 18(2):67-78. PubMed ID: 17397490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cytology quality assurance in Washington State.
    Taylor V; Frost F
    Acta Cytol; 1992; 36(2):246-50. PubMed ID: 1543009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.
    Herbert A; Bergeron C; Wiener H; Schenck U; Klinkhamer P; Bulten J; Arbyn M
    Cytopathology; 2007 Aug; 18(4):213-9. PubMed ID: 17635161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytopathology in Austria.
    Breitenecker G; Dinges HP; Regitnig P; Wiener H; Vutuc Ch
    Cytopathology; 2004 Apr; 15(2):113-8. PubMed ID: 15056173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates.
    Goldzweig CL; Parkerton PH; Washington DL; Lanto AB; Yano EM
    Am J Manag Care; 2004 Apr; 10(4):265-72. PubMed ID: 15124503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.